- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: lenalidomide
Total 1042 results
-
The Lymphoma Academic Research OrganisationActive, not recruitingMantle Cell LymphomaFrance, Spain, Belgium, Netherlands, Germany, Poland, Portugal
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationNot yet recruitingRelapsed or Refractory Follicular Lymphoma
-
AbbVieGenmabRecruiting
-
University of BirminghamCancer Research UK; GenmabRecruitingRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited Kingdom
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Follicular LymphomaUnited States, Spain, United Kingdom, Italy, France, Japan, Germany
-
The First Affiliated Hospital with Nanjing Medical...RecruitingNon Hodgkin Lymphoma | Diffuse Large B Cell LymphomaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Indolent Adult Non-Hodgkin... and other conditionsUnited States
-
Gesellschaft fur Medizinische Innovation - Hamatologie...Celgene; AmgenTerminatedDiffuse Large B-cell Lymphoma (DLBCL) | Burkitt Lymphoma (BL) | Follicular Lymphoma Grade III (FL III°) | Mantle Cell Lymphoma (MCL), Blastoid Variant | Aggressive Marginal Zone Lymphoma (MZL)Germany
-
University of ArkansasAmgenTerminatedMultiple MyelomaUnited States
-
Columbia UniversityCompletedMultiple MyelomaUnited States
-
Michaela LiedtkeCelgene CorporationCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCelgeneCompletedAdvanced CancersUnited States
-
Wuhan Union Hospital, ChinaRecruitingMultiple Myeloma | Extramedullary Multiple Myeloma | Primary Plasma Cell LeukemiaChina
-
Institute of Hematology & Blood Diseases HospitalRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed LymphomaChina
-
University of ArkansasJanssen, LPActive, not recruitingMultiple MyelomaUnited States
-
Stanford UniversityCelgene CorporationCompletedLeukemia | AmyloidosisUnited States
-
Washington University School of MedicineTerminatedMultiple MyelomaUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandUMC Utrecht; Amsterdam University Medical Centers; The Dutch Network for Cardiovascular...Not yet recruitingDLBCL - Diffuse Large B Cell LymphomaNetherlands
-
M.D. Anderson Cancer CenterGenentech, Inc.; CelgeneCompleted
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
GenmabAbbVieRecruitingNon-Hodgkin LymphomaUnited States, France, Israel, Korea, Republic of, Spain, Taiwan, Netherlands, Czechia, Japan, Hungary, Germany, Denmark
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Refractory NeuroblastomaUnited States, Canada
-
CelgeneCompletedLymphoma, Large B-Cell, DiffuseUnited States, Austria, United Kingdom, Estonia, Denmark
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
Robert Redner, MDCephalonCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Janssen, LPCompletedCD20 Positive | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage II Marginal Zone Lymphoma | Ann Arbor Stage III Marginal... and other conditionsUnited States
-
City of Hope Medical CenterWithdrawnSezary Syndrome | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Mycosis Fungoides | Folliculotropic Mycosis Fungoides | CD30-Positive Neoplastic Cells Present | Refractory Primary Cutaneous T-Cell Non-Hodgkin LymphomaUnited States
-
University of MiamiAmgen; Janssen PharmaceuticalsRecruitingMultiple MyelomaUnited States, Sweden
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Grade 3a Follicular LymphomaUnited States
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingRefractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Richter Syndrome | Refractory Mantle Cell Lymphoma | Refractory Aggressive B-Cell Non-Hodgkin Lymphoma | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory... and other conditionsUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
GOG FoundationNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
CelgeneCovanceCompletedHealthyUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGrade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 3 Follicular Lymphoma | Ann Arbor Stage...United States
-
National Cancer Institute (NCI)RecruitingHigh Grade B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminated
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Spain
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Smoldering Plasma Cell Myeloma | Indolent Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | Pleomorphic Variant Mantle Cell LymphomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingFollicular LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States, Puerto Rico
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States